Get the Stockscreener App
1.99
2.93%
-0.06
After Hours:
2.00
0.01
+0.50%
Nuwellis Inc stock is traded at $1.99, with a volume of 74,031.
It is down -2.93% in the last 24 hours and down -39.70% over the past month.
Nuwellis Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.
See More
Previous Close:
$2.05
Open:
$2
24h Volume:
74,031
Relative Volume:
0.77
Market Cap:
$183.48K
Revenue:
$8.77M
Net Income/Loss:
$-19.05M
P/E Ratio:
-0.000887
EPS:
-2243.7675
Net Cash Flow:
$-11.60M
1W Performance:
-33.67%
1M Performance:
-39.70%
6M Performance:
-98.52%
1Y Performance:
-99.53%
1-Day Range:
$1.85
$2.02
1-Week Range:
$1.85
$2.99
52-Week Range:
$1.85
$419.30
Nuwellis Inc Stock (NUWE) Company Profile
Name
Nuwellis Inc
Sector
Industry
Phone
952-345-4200
Address
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Compare NUWE vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
1.99 | 189.01K | 8.77M | -19.05M | -11.60M | -2,243.77 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-24 | Initiated | ROTH MKM | Buy |
Nuwellis Inc Stock (NUWE) Latest News
Nuwellis reports 14% second-quarter revenue growth - grafa.com
Nuwellis, Inc. Provides Unaudited Preliminary Results for Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nuwellis reports 14% revenue growth in Q2 2026, driven by Aquadex platform momentum. - Pluang
Nuwellis Q2 Results: Revenue up 14% YoY, H2 growth hits 20% - scanx.trade
Nuwellis reports 14% revenue growth in second quarter 2026 - Investing.com
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth - The Manila Times
Nuwellis Announces Preliminary Revenue Results For The Second Quarter 2026 Showing Double Digit Growth - TradingView
Nuwellis’ new CEO on building a strong foundation for sustainable value creation - Yahoo Finance
Nuwellis Inc (NUWE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nuwellis, Inc. Revenue Breakdown – NASDAQ:NUWE - TradingView
TradingKey - TradingKey
NUWE|Nuwellis Inc|Price:2.050|Chg%:-0.150 - TradingKey
Nuwellis, Inc. Proposes Reverse Stock Split to Maintain Nasdaq Listing – SEC Form 8-K Filing July 2026 - Minichart
Nuwellis Shareholders Approve Reverse Stock Split Authorization - TipRanks
Nuwellis Inc (NUWE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nuwellis Inc. (NUWE) Rallies 5.26% as Stock Tests Key ResistanceBPI Bull Correction - dars.gov.et
Nuwellis secures new US patent for dual-lumen catheter technology - MSN
NUWE News | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis receives patent for dual lumen catheter technology By Investing.com - Investing.com Nigeria
Nuwellis awarded U.S. patent for Dual Lumen Catheter - TipRanks
Nuwellis wins U.S. patent for a catheter that i... - Pluang
Nuwellis (NUWE) Secures Patent for Innovative Catheter Technology - GuruFocus
Nuwellis receives patent for dual lumen catheter technology - Investing.com
Nuwellis Receives U.S. Patent for Dual Lumen Catheter for Extracorporeal Therapies - Quiver Quantitative
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies - The Manila Times
Nuwellis Catheter Design Lets Clinicians Trim Length for Patients - Stock Titan
NUWE Q1 2026 Earnings: Significant EPS Miss Amidst Stock Price IncreaseEarnings Beat Alert - dars.gov.et
Nuwellis names Mike McCormick as CEO - MSN
NUWE Q1 2026 Earnings: Massive EPS Miss as Company Reports No RevenueNegative Surprise Momentum - dars.gov.et
Form DEF 14A Nuwellis Inc For: 7 July By Investing.com - Investing.com Nigeria
Nuwellis (NASDAQ: NUWE) seeks warrant share and reverse split votes - Stock Titan
Nuwellis to showcase Aquadex therapy at KidneyB... - Pluang
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 - The Manila Times
Nuwellis takes Aquadex to a pediatric kidney conference in Colorado - Stock Titan
Nuwellis Inc. (NUWE) Bounces From Support, Testing Resistance After 5.4% GainOption Breadth - dars.gov.et
NUWE Q1 2026 Earnings: Significant EPS Miss Highlights Persistent Cost PressuresBuyback Announcement Report - dars.gov.et
NUWENuwellis Inc Short Interest - Finviz
Nuwellis (NASDAQ: NUWE) CEO McCormick files initial insider Form 3 - Stock Titan
NUWE Q1 2026 Earnings: EPS Miss of 104.9% Sends Shares LowerNext Quarter Guidance - dars.gov.et
Nuwellis Inc (FRA:22S1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CHF Solutions, Inc.Special Call Transcript - GuruFocus
Nuwellis Inc (FRA:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Revenue per share of Nuwellis, Inc. – FWB:22S1 - TradingView
Price to cash flow ratio of Nuwellis, Inc. – FWB:22S1 - TradingView
Average basic shares outstanding of Nuwellis, Inc. – FWB:22S1 - TradingView
Net income of Nuwellis, Inc. – FWB:22S1 - TradingView
NUWELL.INC.NEW26 DL-,0001 Financial Statements – FWB:22S1 - TradingView
Nuwellis, Inc. Income Statement – FWB:22S1 - TradingView
Enterprise value to EBITDA forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Price to earnings forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Nuwellis Inc Stock (NUWE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):